In PC cells, the NUP210 gene is specifically targeted downstream of androgen receptor (AR) splice variant-7 (AR-V7) activity which drives the progression of primary PC to castration-resistant prostate cancer (CRPC) (77). The gene discussed is AR; the disease is pachyonychia congenita.